The evolving role of cyclin-dependent kinase inhibitors in cancer management.
The evolving role of cyclin-dependent kinase inhibitors in cancer management.
Clin Adv Hematol Oncol. 2017 Mar;15(3):174-177
Authors: Shapiro GI
PMID: 28398270 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research